Literature DB >> 33899339

Different Indicators of Adiposity and Fat Distribution and Cardiometabolic Risk Factors in Patients with Type 2 Diabetes.

Li Ding1, Yuxin Fan1,2, Jing He1, Ruodan Wang1, Qing He1, Jingqiu Cui1, Zhongshu Ma1, Fangqiu Zheng1, Hua Gao1, Chenlin Dai1, Hongyan Wei1, Jun Li1, Yuming Cao1, Gang Hu2, Ming Liu1.   

Abstract

OBJECTIVE: This study aimed to evaluate the effect of adiposity and fat distribution on the odds of elevated cardiovascular risk factors among adults with type 2 diabetes mellitus.
METHODS: The present cross-sectional study included 2,427 adults with type 2 diabetes mellitus. Body fat was assessed by dual-energy x-ray absorptiometry. Multivariate-adjusted logistic regression was used to estimate effects of adiposity parameters on elevated hemoglobin A1c (HbA1c , ≥7.0%), hypertension (blood pressure ≥140/90 mmHg), and elevated low-density lipoprotein (LDL) cholesterol (≥2.6 mmol/L).
RESULTS: The multivariable-adjusted odds ratio (OR) for elevated HbA1c was 0.82 (95% CI: 0.70-0.96) for each SD increase in leg fat mass. The multivariable-adjusted OR for hypertension was 1.15 (95% CI: 1.00-1.32) for each SD increase in android fat mass. Multivariable-adjusted ORs for elevated LDL cholesterol ranged from 1.16 (95% CI: 1.00-1.35) to 1.27 (95% CI: 1.06-1.51) for each SD increase in arm and android fat mass and percentage of total, truncal, arm, and android fat. Each SD increase in BMI, truncal-to-leg fat ratio, and android-to-gynoid fat ratio was significantly associated with increased risks of elevated HbA1c , hypertension, and elevated LDL cholesterol.
CONCLUSIONS: Subcutaneous fat in the lower body was associated with a more favorable glycemic profile, but not blood pressure or lipid profile, whereas central adiposity was associated with poor control of cardiovascular risk factors among patients with type 2 diabetes mellitus.
© 2021 The Obesity Society.

Entities:  

Mesh:

Year:  2021        PMID: 33899339      PMCID: PMC9115840          DOI: 10.1002/oby.23151

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   9.298


  39 in total

Review 1.  Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?

Authors:  Adrian Brown; Nicola Guess; Anne Dornhorst; Shahrad Taheri; Gary Frost
Journal:  Diabetes Obes Metab       Date:  2017-07-13       Impact factor: 6.577

2.  Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes.

Authors:  Gang Hu; Pekka Jousilahti; Noël C Barengo; Qing Qiao; Timo A Lakka; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

3.  Sympathetic neural activation in visceral obesity.

Authors:  Guy E Alvarez; Stacy D Beske; Tasha P Ballard; Kevin P Davy
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

4.  Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway.

Authors:  Partha Chakrabarti; Ju Youn Kim; Maneet Singh; Yu-Kyong Shin; Jessica Kim; Joerg Kumbrink; Yuanyuan Wu; Mi-Jeong Lee; Kathrin H Kirsch; Susan K Fried; Konstantin V Kandror
Journal:  Mol Cell Biol       Date:  2013-07-15       Impact factor: 4.272

5.  Relative fat mass is a better predictor of dyslipidemia and metabolic syndrome than body mass index.

Authors:  Ofer Kobo; Ronit Leiba; Ophir Avizohar; Amir Karban
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-09-10

6.  Trunk versus extremity adiposity and cardiometabolic risk factors in white and African American adults.

Authors:  Gang Hu; Claude Bouchard; George A Bray; Frank L Greenway; William D Johnson; Robert L Newton; Eric Ravussin; Donna H Ryan; Peter T Katzmarzyk
Journal:  Diabetes Care       Date:  2011-04-19       Impact factor: 19.112

Review 7.  Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome.

Authors:  Juan Antonio Paniagua
Journal:  World J Diabetes       Date:  2016-11-15

8.  Tofogliflozin decreases body fat mass and improves peripheral insulin resistance.

Authors:  Ren Matsuba; Ikuro Matsuba; Mototsugu Shimokawa; Yoshio Nagai; Yasushi Tanaka
Journal:  Diabetes Obes Metab       Date:  2018-02-04       Impact factor: 6.577

9.  Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk.

Authors:  S K Vasan; C Osmond; D Canoy; C Christodoulides; M J Neville; C Di Gravio; C H D Fall; F Karpe
Journal:  Int J Obes (Lond)       Date:  2017-11-20       Impact factor: 5.095

10.  Android Fat Deposition and Its Association With Cardiovascular Risk Factors in Overweight Young Males.

Authors:  Carolina Ika Sari; Nina Eikelis; Geoffrey A Head; Markus Schlaich; Peter Meikle; Gavin Lambert; Elisabeth Lambert
Journal:  Front Physiol       Date:  2019-09-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.